Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2.
Anwaar MU, Adnan F, Abro A, Khan RA, Rehman AU, Osama M, Rainville C, Kumar S, Sterner DE, Javed S, Jamal SB, Baig A, Shabbir MR, Ahsan W, Butt TR, Assir MZ.
Anwaar MU, et al. Among authors: abro a.
Comput Biol Med. 2022 Feb;141:105049. doi: 10.1016/j.compbiomed.2021.105049. Epub 2021 Nov 20.
Comput Biol Med. 2022.
PMID: 34823857
Free PMC article.